Phase I Study of [111In]-FPI-2107 in EGFR Mutation-positive NSCLC
Clinical trial NCT07500987 · RECRUITING
Trial details
- NCT number
- NCT07500987
- Sponsor
- AstraZeneca
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-27
- Primary completion
- 2026-07-21
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.